US2012225441A1PendingUtilityA1

Protein markers for detecting liver cancer and method for identifying the markers thereof

42
Assignee: HSIEH SEN-YUNGPriority: Jul 7, 2010Filed: May 16, 2012Published: Sep 6, 2012
Est. expiryJul 7, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Sen-Yung Hsieh
G01N 33/57525G01N 2333/71G01N 2333/65
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of liver cancer from a liquid sample, derived from an individual by measuring ERBB3 protein and IGFBP2 protein in the sample. Measurement of ERBB3 protein and IGFBP2 protein can, e.g., be used in the early detection or diagnosis of liver cancer.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . A method of detecting the presence of liver cancer in a person comprising detecting IGFBP2 biomarker for liver cancer detection that contains SEQ ID NO: 4 in said person by using an antibody specific for binding an IGFBP2 protein. 
     
     
         9 . (canceled)

Join the waitlist — get patent alerts

Track US2012225441A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.